Comparing ultrasound and CT-guided lung biopsies for diagnosing lung lesions
Official title: A Prospective, Randomized, Multicentric and Single-blinded Study on Accuracy and Safety of Ultrasound (US) Guided Percutaneous Needle Biopsy of Peripheral Lung Lesion Compared With Computed TomogrAphy (CT) Guided Needle Biopsy
Run by University Hospital of Ferrara · NCT06412289 · Data updated 2026-11-12
This study is testing whether ultrasound-guided lung biopsies are better or safer than CT-guided biopsies for diagnosing lung lesions in patients.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 90 Years |
| Sex | All |
| Enrollment | 236 (estimated) |
| Sponsor | University Hospital of Ferrara Academic / other |
| Drugs / interventions | radiation |
| Locations | 2 sites (Ferrara and 1 other locations) |
| Status | Recruiting |
| Started | March 8, 2024 |
| Main results expected | April 30, 2026 |
| Study ends | October 31, 2026 |
| Registry record updated | December 6, 2024 |
| Trial ID | NCT06412289 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults over 18 years old with peripheral pulmonary lesions that are adherent to the thoracic wall as indicated by CT scans.
✕Probably not a fit
Patients with terminal neoplastic diseases, severe organ failure, or those unable to provide informed consent will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to compare the diagnostic accuracy of ultrasound-guided percutaneous lung biopsies with CT-guided biopsies in patients with peripheral lung lesions. It is a prospective randomized single-blind multicenter interventional study that will assess not only the accuracy of these two methods but also the onset of complications, exposure to ionizing radiation, patient comfort, and the duration of the procedures. The goal is to determine which method provides a safer and more effective means of diagnosing lung lesions, particularly given the increasing incidence of such lesions due to enhanced imaging techniques.
Why it matters
Potential benefit: If successful, this study could lead to improved diagnostic methods for lung lesions, reducing complications and enhancing patient comfort.
How similar studies have gone: Previous studies have shown varying success with similar diagnostic approaches, but this specific comparison of ultrasound versus CT guidance is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Willingness and ability to provide free and informed consent. Age older then 18 years old. * Peripheric pulmonary lesions adherent to the thoracic wall in CT scans with indication to typing Exclusion Criteria: * Inability to provide free and informed consent, in the absence of an available legal guardian. * Age younger then 18 years old. * Terminal neoplastic diseases/ palliative care patients. * Patients with one lung, anatomical of functional. * Severe non-treatable blood clothing disfunctions. * Severe organ failure (pulmonary, renal, hepatic or cardiac). * Women in state of pregnancy.
Where it's running
-
UO Pneumologia AOSP-AUSL
Ferrara, Italy Recruiting -
UOC Pneumologia - Azienda ospedaliera A. Cardarelli
Naples, Italy Recruiting
Study contacts
- Principal investigator: Mario Tamburrini, Dr. — Arcispedale Sant'Anna
- Study coordinator: Ludovica Tamburrini, Dr
- Email: ludovica.rizzo14@gmail.com
- Phone: 3337944389
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Shape-sensing robotic bronchoscopy to diagnose peripheral lung nodules
This tests a shape-sensing robotic bronchoscopy to see if it can get tissue samples from adults in Korea with peripheral lung nodules.
-
Diagnosing Peripheral Lung Lesions With Cryo Biopsies
A study to see if cryo biopsies taken through a bronchoscope can better diagnose small lung lesions than the usual forceps biopsies in adults undergoing lung cancer workups.
-
CLE vs ROSE for ex vivo lung biopsy assessment in peripheral pulmonary lesions
This study tests whether Confocal Laser Endomicroscopy can match Rapid On-Site Evaluation for diagnosing peripheral lung lesions from biopsy samples.
-
Contrast-enhanced endobronchial ultrasound for lung lesions and chest lymph nodes
This test checks whether adding a microbubble contrast agent to endobronchial ultrasound helps diagnose lung lesions and enlarged intrathoracic lymph nodes in adults who need EBUS-TBNA.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.